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Abstract
The ability to perform large-scale, expression-based chemogenomics on whole adult organisms, as in invertebrate models
(worm and fly), is highly desirable for a vertebrate model but its feasibility and potential has not been demonstrated. We
performed expression-based chemogenomics on the whole adult organism of a vertebrate model, the zebrafish, and
demonstrated its potential for large-scale predictive and discovery chemical biology. Focusing on two classes of compounds
with wide implications to human health, polycyclic (halogenated) aromatic hydrocarbons [P(H)AHs] and estrogenic
compounds (ECs), we generated robust prediction models that can discriminate compounds of the same class from those of
different classes in two large independent experiments. The robust expression signatures led to the identification of
biomarkers for potent aryl hydrocarbon receptor (AHR) and estrogen receptor (ER) agonists, respectively, and were
validated in multiple targeted tissues. Knowledge-based data mining of human homologs of zebrafish genes revealed
highly conserved chemical-induced biological responses/effects, health risks, and novel biological insights associated with
AHR and ER that could be inferred to humans. Thus, our study presents an effective, high-throughput strategy of capturing
molecular snapshots of chemical-induced biological states of a whole adult vertebrate that provides information on
biomarkers of effects, deregulated signaling pathways, and possible affected biological functions, perturbed physiological
systems, and increased health risks. These findings place zebrafish in a strategic position to bridge the wide gap between
cell-based and rodent models in chemogenomics research and applications, especially in preclinical drug discovery and
toxicology.
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Introduction
Chemogenomics, application of genomic tools in pharmacology
and toxicology, offers a promising approach that will enhance
drug discovery (target identification/validation, lead identification,
efficacy evaluation) and toxicity assessment [1,2]. Presently,
invertebrates such as the worm Caenorhabditis elegans and fly
Drosophila melanogaster, are the only animal models that have
benefited from whole-adult-organism expression chemogenomics
[3–6]. The benefits of whole-adult-organism chemogenomics
would usually translate into large-scale, high-throughput, high-
content and cost-effective applications for chemical biology. It is
highly desirable that the benefits of whole-adult-organism
chemogenomics can be realized in a vertebrate model because
of the many biological processes, health risks and diseases that are
restricted to a mature vertebrate system including humans. The
existing cell-, fly- and worm-based models, while suited for high-
throughput chemogenomics, lacked the relevant physiological
whole-organism setting of an adult vertebrate. This is especially
important in the context of pharmacology and toxicology when
many of the potentially targeted organ-systems such as the
endocrine, digestive (liver in particular), immune, muscular-
skeletal, vasculature, kidney are absent from the existing high-
throughput models. In contrast, the rodent models, though
providing in vivo adult vertebrate data, are not suited for high-
throughput applications and are not cost-effective [7], thus
creating a bottleneck situation when in vivo biological data,
especially toxicology, is required for the high number of ‘hits’
generated from in vitro screenings or for the many newly emerging
industrial compounds and waste that are coming into contact with
the public and environment. We propose that whole-adult
chemogenomics performed on a small vertebrate such as the
zebrafish would be a strategy that is sufficiently high-throughput,
cost-effective and would generate high content in vivo vertebrate
data potentially useful for large-scale screening and toxicity testing
purposes.
Conceptually, whole-adult-organism expression chemoge-
nomics would capture the sum-total of the transcriptomic changes
in an entire adult organism as a single biological entity responding
to exogenous chemical cues. This, however, would have its
inherent limitations such as loss of weak signals or signals from
smaller tissues and loss of specific location of response, and they
may be compounded further by the greater biological complexity
in vertebrates compared to invertebrates. Thus, while whole-adult-
organism chemogenomics had been shown to be useful in
invertebrate models with regard to compound screening [3,4]
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[5,6], it is not known if chemogenomics data generated from a
whole adult vertebrate will be useful. We hypothesized that since
strong and well-represented expression signals are likely to be
detected in whole-adult-organism chemogenomics, the expression
signals that are captured would be robust for predictive chemical
biology and for uncovering biology that is widely associated with
the chemical-induced responses/effects in the adult vertebrate.
However, the idea of performing high-throughput whole-adult-
organism chemogenomics on a vertebrate model was practically
not feasible, if not unimaginable, until microarray technology was
made available to small aquarium fish such as the zebrafish. The
availability of the zebrafish in large numbers, its small size, low
husbandry cost, vast genomic resources and its present use in
disease modeling [8] and drug screening [9,10], make the
zebrafish ideal for high-throughput whole-adult-organism chemo-
genomics. Moreover, owing to their close physiological relation-
ship with the environment, fish are highly sensitive to environ-
mental changes particularly exogenous chemical cues; therefore
the impact of chemical effects on fish system is more easily defined
and readily studied than on terrestrial species [11]. Previously, we
and others have shown that zebrafish responded biologically to
chemicals, such as small molecules, drugs and environmental
toxicants, in a similar manner as mammals [12–16]. In this study,
we chose P(H)AHs [represented by Benzo[a]pyrene (BAP), 3-
Methylcholanthrene (MC), 2,3,7,8-Tetrachlorodibenzodioxin
(TCDD)] and ECs [represented by 17-beta estradiol (Es),
Diethylstilbestrol (DES), Bisphenol A (Bis)] as model compounds
because they represent two classes of chemicals with wide
implications to human health. Both P(H)AHs and ECs are potent
AHR and ER agonists, respectively, and these receptors are
known to cross-talk and they are regulators of important cellular
functions that are involved in various biological processes and have
been associated with several patho-physiological conditions [17–
19]. Some of these compounds have been used as drugs or
investigated for therapeutic potential [20–22]. Moreover, both
classes of compounds are also environmental carcinogens and
endocrine disruptors that have generated considerable public
health concern [23,24]. By focusing on P(H)AHs and ECs in this
study, we performed chemogenomics on whole adult zebrafish and
demonstrated that it is good for large-scale predictive chemical
biology, for discovering biomarkers and major signaling pathways,
as well as useful for human health risk and biological insight
inference. Our study placed zebrafish in a strategic position to
bridge the gap between in vitro cell-based model and in vivo rodent
model in chemogenomics.
Results/Discussion
Robust Predictive Power of Zebrafish Whole-Adult-
Organism Chemogenomics
We generated 159 samples/arrays involving 28 treatment
groups (4–7 replicates in each treatment group) in two experiments
(‘A’ and ‘B’) and grouped them into four Datasets: I and II from
experiment ‘A’ while III and IV from experiment ‘B’ (See
Methods, Table S1 and Figure S1). Experiments ‘A’ and ‘B’ were
performed one year apart using different batches of fish, reference
RNA, reagents, array prints and experimental designs, which will
test the robustness of the prediction models and help in identifying
robust biomarkers. We trained six prediction models using Dataset
I (Figure 1A and 1B) and validated them independently on
Datasets II, III and IV (Figure 1C–1E). The validations were
‘independent’ in the sense that Datasets II, III and IV were totally
left out and not used in the training of the prediction models that
were tested on. Next, we trained another six prediction models
using Dataset III (Figure 2A and 2B) and performed similar
independent validation on the ‘unseen’ Datasets I, II and IV
(Figure 2C–2E). The prediction models were trained using two
supervised learning classifiers, k-nearest neighbours (kNN) and
support vector machine (SVM), on selected discriminatory gene
sets from Dataset I or III. During the training phase, the
supervised learning classifiers used the individual discriminatory
gene sets together with their expression data in Dataset I or III to
produce respective sets of rules or reference weights that will serve
as standards/models for the prediction of ‘unseen’ or unknown
samples. The discriminatory gene sets for P(H)AH and EC classes
were selected using threshold criteria of Q-value, FDR-value or P-
value coupled with fold-difference between treated [combined
representative groups of P(H)AHs or ECs] versus control samples
in Dataset I or Dataset III (Figure 1A and 2A; details of criteria in
Table S2). The different statistical treatments and learning
classifiers were used to examine if any idiosyncrasy associated
with data processing affected the performances of the prediction
models.
First, we evaluated the prediction models using ‘leave-one-out’
cross-validation approach to avoid the statistical problem of over-
estimating prediction accuracy that occurs when a model is trained
and evaluated with the same samples. In this procedure, one of the
30 or 25 samples from Datasets I or III, respectively, was withheld
and the remaining 29 or 24 of the respective samples were used to
train a prediction model based on a selected discriminatory gene
set to predict the class of the withheld sample. The process was
repeated until all 30 or 25 samples were predicted in turn, and all
prediction models were tested similarly. We found that the
‘Predicted Results’ for all the samples matched the ‘Expected
Results’, hence 100% of the samples were correctly classified by all
the prediction models (Figure 1B and 2B). The excellent
performances of the prediction models were non-random (Fisher’s
Exact Test P-value=8.35610
2924.89610
27; Table S3), indicat-
ing their predictive powers.
Author Summary
To understand chemical-induced biological responses/
effects, it is important to have large-scale and rapid
capacity to investigate gene expression changes caused by
chemical compounds at genome-wide scale in an adult
vertebrate model; this capability is essential for drug
development and toxicology. Small aquarium fish with
vast genomic resources, such as zebrafish, will probably be
the only vertebrate models that allow for cost-effective,
large-scale, genome-wide determination of gene expres-
sion net changes in the entire adult organism in response
to a chemical compound. Presently, such a whole adult
organism approach is only feasible in invertebrate models
such as the worm and fly, and not in rodent models, hence
the usefulness of such an approach has not been
demonstrated in a vertebrate. By using two classes of
chemicals with wide implications to human health, we
showed that capturing net changes of gene expression at
a genome-wide scale in an entire adult zebrafish is useful
for predicting toxicity and chemical classes, for discovering
biomarkers and major signaling pathways, as well as for
inferring human health risk and new biological insights.
Our study provides a new approach for genome-wide
investigation of chemical-induced biological responses/
effects in a whole adult vertebrate that can benefit the
drug discovery process and chemical toxicity testing for
environmental health risk inference.
Zebrafish Chemogenomics
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validate them independently. In this procedure, we used the 30
samples from Dataset I to train prediction models based on the
selected discriminatory gene sets and predict each of the 25
‘unseen’ samples from Dataset III. Remarkably, the prediction
models for P(H)AHs and ECs trained by Dataset I classified 100%
of the samples in Dataset III correctly (Figure 1C). We then
reversed the order by training the prediction models with the 25
samples from Dataset III and testing them on each of the 30
samples from Dataset I. The prediction models for P(H)AHs
Figure 1. Performance of P(H)AH and EC prediction models trained using discriminatory gene sets from Dataset I. (A) The prediction
models were generated by two supervised learning classifiers, k-nearest neighbours (kNN) and support vector machine (SVM), using the discriminatory
gene sets selected based on different statistical thresholds Q-val, FDR-val and P-val. (B) The prediction models were self-evaluated using ‘leave-one-out’
cross-validation approach followed by independent cross-validation using ‘unseen’ (C) Dataset III, (D) Dataset II and (E) Dataset IV. The labels indicating
the actual treatment group for each sample/array are shown on the left side of each dataset panel with the corresponding ‘Expected Results’ columns
(bold-lined cells; see Table S1 for detailed information of each label/sample). The remaining columns in groups of three are the ‘Predicted Results’
generated by the prediction models (See Table S2 for information of the gene sets). Red cell indicates presence or positive identification of a class of
compound and green cell indicates absence or negative identification of it (see Table S3 for detailed performance of each prediction model).
doi:10.1371/journal.pgen.1000121.g001
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correctly while the prediction models for ECs performed
comparably well though with one or two false negatives
(Figure 2C). The findings indicate that the prediction models
were remarkably robust because both Datasets I and III were
obtained through two separate experiments that contained
substantial biological and technical variations.
Next, we tested the specificity (the ability to identify negative
cases) of the above prediction models on 9 types of compounds
from classes with acute mode-of-action and toxicity effects
differing from that of P(H)AHs and ECs. Thus, we tested each
of the prediction models generated using the 30 and 25 samples
from the respective Datasets I and III, on each of the 46 ‘expected-
negative’ samples from Dataset II, independently. As anticipated,
Figure 2. Performance of P(H)AH and EC prediction models trained using discriminatory gene sets from Dataset III. (A) The prediction
models were generated by two supervised learning classifiers, k-nearest neighbours (kNN) and support vector machine (SVM), using the
discriminatory gene sets selected based on different statistical thresholds Q-val, FDR-val and P-val. (B) The prediction models were self-evaluated
using ‘leave-one-out’ cross-validation approach followed by independent cross-validation using ‘unseen’ (C) Dataset I, (D) Dataset II and (E) Dataset IV
(see Figure 1 legend for remaining description).
doi:10.1371/journal.pgen.1000121.g002
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matching the ‘Expected Results’ (Figure 1D and 2D). The robust
performance of the prediction models generated from Dataset III
is noteworthy since both Datasets II and III were derived from
different experiments.
We also tested the performance of the prediction models on
Dataset IV consisting of 58 samples obtained from fish exposed to
multiple chemical mixture of BAP, DES and arsenic (As) at
different concentrations and combinations. Arsenic was intro-
duced to increase the complexity of the mixtures and to test if the
prediction models could still perform well on samples exposed to
mixtures consisting of a chemical not used in the training of the
models. The performance of the prediction models for ECs was
outstanding as they could classify 100% of the samples correctly
notwithstanding the increase complexity that could arise from the
mixture of compounds and that Datasets I and IV are from
separate experiments (Figure 1E and 2E). The prediction models
for P(H)AHs displayed comparable performances in terms of
specificity although the sensitivity (ability to identify positive cases)
varied from 62.5%–97.5% (Table S3). Notably, prediction models
of P(H)AHs trained from Dataset I performed poorer on Dataset
IV compared to those trained from Dataset III, suggesting that
when mixtures were involved, the performance of the P(H)AH
models were affected by the inter-experimental variations. In this
case, different statistical approaches can affect prediction perfor-
mance, but with appropriate statistical tests, it is possible to
generate prediction models that are sufficiently robust. This was
observed in the case of SVM-trained P(H)AH models using
discriminatory gene sets from Dataset I selected based on FDR-val
(sensitivity=92.5%) and P-val (sensitivity=90.0%) which per-
formed better compared to Q-val (sensitivity=62.5%) (Table S3).
Taken together, with the exception of Q-val_P(H)AH perfor-
mance on Dataset IV, all the prediction models performed
comparably well, in particular for most of ECs which scored 100%
for specificity and sensitivity. The robust ability of the prediction
models to discriminate compounds of the same class from those of
different classes, even in a mixture of compounds, suggests that
zebrafish whole-adult-organism chemogenomics is capturing genes
associated with biological functions that are strongly affected by a
class of compound. This demonstrates its potential use for
compound screening, predictive chemical biology and biomarker
discovery. The ability of the prediction models to tolerate a
reasonable level of biological, technical and data-processing
variations, indicate high amenability to real-life compound
screening and predictive applications as such variations will
inevitably occur over time, in different laboratories and experi-
mental settings.
Identification of Potential Biomarker Genes and Signaling
Pathways
Having demonstrated their predictive powers, we used the
discriminatory gene sets to identify potential biomarker genes for
P(H)AHs and ECs. To do so, we first consolidated the
discriminatory gene sets into their corresponding two major
groups P(H)AHs and ECs by combining the gene sets within their
respective classes (including only genes with unique GenBank
Identity and similar mean expression directionality). Then, we
examined the consistency of their expression profiles throughout
all the 28 treatment groups in this study and validated some of the
responsive genes using quantitative real-time PCR. A two-way
hierachical clustering showed that the consolidated gene sets were
able to cluster tightly the respective treatment groups including
those in the mixture groups from the non-P(H)AH (Figure 3A) or
non-EC treatment groups (Figure 3B). However, the gene
expression profiles formed in the EC gene set (Figure 3B) were
more distinct compared to the P(H)AH gene set (Figure 3A). This
is due to the large number of genes that are specifically affected by
ECs compared to the presence of certain xenobiotic metabolism or
stress response-associated genes shared between P(H)AHs and
other compounds, as well as the presence of some genes whose
expressions are affected by compound mixtures. A closer
examination of the genes reveals that ahr2 and its known
regulated/responsive genes [25] such as cyp1A1, NQO1 homolog,
nfe2l2, TIPARP homolog, gstp1, cyp1C1 were among the genes
found in a tight cluster that shows similar expression pattern across
the P(H)AH treatment groups (Figure 3A). Likewise, esr1 and its
known regulated/responsive genes [26,27] such as vg1 and vg3,
nots, XBP1 homolog, NUPRI/P8 homolog were among the genes
found in a tight cluster that shows consistent expression pattern
across the ECs (Figure 3B). The findings indicate that zebrafish
whole-adult-organism chemogenomics is able to capture impor-
tant genes associated with major signaling pathways such as AHR
and ER that are deregulated by the compounds. More
importantly, the presence of many unknown genes clustering
together with the known P(H)AH- or estrogen-responsive genes,
suggests that these are potential novel biomarkers for P(H)AHs
and ECs, respectively. The consistent expression patterns across
several treatment groups containing P(H)AHs or ECs from two
different experiments highlights the robustness of these biomarker
genes.
In addition, we have independently validated 27 and 28 genes
that were significantly (P-value ,0.05) deregulated in the BAP and
DES groups, respectively, using quantitative real-time PCR. We
later observed that 16 and 21 of these genes were in the
consolidated discriminatory gene sets of P(H)AHs and ECs,
respectively (Figure 3; Table S4). As expected, there are a large
number of significantly deregulated genes that are excluded in the
discriminatory gene sets due to non-fulfillment of the stringent
selection criteria but they are nevertheless responsive to BAP and/
or DES. The good concordance of the microarray and PCR
results for these genes gave us the confidence to pin down these
biomarkers at the tissue level.
Biomarker Discovery in Targeted Tissues
To confirm these biomarkers and obtain insights in targeted
tissues, we performed a third independent experiment ‘C’ (Table
S1) by treating zebrafish with BAP or DES followed by
quantitative real-time PCR assay for the previously validated
genes (Table S4) in seven tissue types (brain, gills, liver, gut, skin,
testis and eyes). Out of the 27 and 28 validated genes for BAP and
DES respectively, a total of 81 and 99 positive hits [significant
gene deregulation (T-Test P-value ,0.05)] were detected among
the seven tissues (Table 1 and 2; Figure S2). About 37.0% (10/27)
and 53.6% (15/28) of the validated genes in BAP and DES,
respectively, were deregulated in 4–7 (.50%) of the selected
tissues making them excellent biomarker genes for the respective
class of compounds (Table 1 and 2). Among these 10 and 15
biomarkers for BAP and DES, respectively, 3 are well-known
P(H)AH-responsive genes (ahr2, cyp1A1, and TIPARP homolog)
and another 3 are well-known EC-responsive genes (esr1, vg1, and
vg3), while the remainder 19 are potentially novel as their
responsiveness to these compounds are relatively unknown/
unreported especially within multiple tissue types. The P(H)AH
biomarker genes are mainly associated with xenobiotic metabolism
while the EC biomarker genes are mainly associated with
molecular transport, metabolism and blood factors. Notably,
about 90% (22/25) of these biomarker genes were found in the
consolidated discriminatory gene sets. The remaining genes that
Zebrafish Chemogenomics
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tissue-specific analysis. Less than 10% of the validated genes in the
tissues were found to be inconsistent with the whole fish data and
this could be due to having not selected the appropriate responsive
tissues or biological variations and cumulative effects of several
tissues in the whole fish.
Among the selected tissues, eye and skin had the most BAP-
responsive genes (63.0% and 51.9% of the validated genes,
respectively) followed by gill, liver and testis (40.7% each tissue);
these tissues yielded 79.1% of the total positive hits (Table 1;
Figure S2). The findings are consistent with mammalian data as
these organs (eye, skin, lung, liver and testis) are also known
P(H)AH-targeted tissue in mammals [24,28,29]. As for tissues with
the most DES-responsive genes, liver (92.9%) followed by gut
(67.9%) and skin (60.7%) contributed to 62.6% of the total positive
hits (Figure S2). The identification of these non-classical estrogen-
targeted tissues is consistent with our previous data [30] as well as
mammalian data [19,31]. Activation of AHR or ER signaling
pathways, as suggested by up-regulation of known responsive
genes, was observed in many of these tissues. Interestingly, cyp1A
which was up-regulated by BAP in all 7 tissues, was down-
regulated by DES in 5 tissues, suggesting occurrence of similar
inhibitory cross-talk between AHR and ER reported in mamma-
lian cells [17,18,32]. Taken together, the findings show that the
zebrafish shares similar biological responses in terms of molecules,
signaling pathways and targeted tissues with mammalian system
and is therefore a useful model for inference of chemical biology
and health-risk inference in humans.
Biological Function and Human Health-Risk Inferences
To evaluate the potential for extracting biological insights and
health-risk inferences in humans, we mapped the consolidated
discriminatory gene sets for P(H)AHs and ECs to available
corresponding human homologs as previously described [14] and
used them for knowledge-based data mining via Ingenuity
Pathway Analysis (IPA) software (Figure 4A and 5A). Remarkably,
the analysis of the human homologs from the consolidated
P(H)AH and EC gene sets listed many affected molecular and
cellular functions, perturbed physiological systems and human
diseases/disorders that are known to be associated with these
compounds [19,23,24,28–31] (Figures 4 and 5; Tables S5 and S6).
These also include canonical signaling pathways such as
xenobiotic mechanism signaling (AHR, CYP1A, CYP1B1,
CYP2C19, GSTP1, HSP90A, NFE2L2, NOS2A, NQO1,
SULT2B1), ERK-MAPK signaling (EFL3, RAC1, STAT1,
RPS6KA1) and PPARa/RXRa activation (CYP2C19, HSP90A,
Figure 3. Identification of potential biomarker genes. Two-way hierarchical clustering of the consolidated discriminatory gene sets for (A)
P(H)AHs and (B) ECs versus all the treatment groups used in the present study. Each cell represents the relative (log2) mean expression level of a gene
between the corresponding treatment group and the respective control (vehicle) group [i.e. after subtracting respective control group]. Tight clusters
of P(H)AH and EC treatment groups (including mixture groups) are indicated by ‘cluster branches’ in red. Known responsive genes to the respective
class of compound/compound are indicated by ‘,’. Genes validated by quantitative real-time PCR are indicated by ‘+’ (see Table S4 for PCR validation
information).
doi:10.1371/journal.pgen.1000121.g003
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metabolism (ACSL4, CYP1A1, CYP2C19, CYP51A1), protein
ubiquitination pathway (PSMB6, PSMC2, PSMC5/SUG1,
PSMC6, PSMD13) and coagulation cascade (FGB, SERPINA1,
SERPINC1) for EC gene set. A correlation can be observed
between these biological associations suggesting that prolonged or
substantial perturbation of these biological functions (Figures 4B
and 5B) and physiological systems (Figures 4C and 5C) by a
compound would increase the susceptibility/risk of certain
diseases/disorders (Figures 4D and 5D). Significantly, cancer was
listed among the top most (Fisher Exact Test P-val-
ue=1.98610
2524.76610
22) associated disease as most P(H)AHs
and some ECs are potent carcinogens. In addition, reproductive
system disease, inflammatory disease, hematological disease and
neurological disease were significantly associated with both
P(H)AHs and ECs as the two classes of compounds are known
to affect molecules and functions involved with reproductive
system, inflammation, blood and nervous system (Figures 4C–D
and 5C–D). Interestingly, the association of psychological
disorders with ECs were also significant (P-val-
ue=3.34610
2423.72610
22; Table S6). While it is well-known
that estrogen affects mental health [33], the grouping of ESR1
with GPX4, PSMC6, DIABLO, FBXO9, XBP1 homologs which
have been associated with bipolar disorder [34,35] suggests that
these molecules may also play a role in estrogen-related
psychological disorders (Table S6). Several of these patho-
Table 1. Real-Time PCR validated genes for identification of biomarkers in selected tissue samples from fish treated with BAP
(250ug/L) for 72 hours.
Tissue Types (Log2 Fold Difference Treated vs. Normal) ***
Number of
Positive
Tissue
GenBank Acc Description
Whole
Fish Brain Gill Liver Gut Skin Testis Eye
AW342687 Cytochrome P450,1A ** 5.44 6.04 7.20 3.75 5.12 6.91 5.55 6.51 7
#
AF057713 Cytochrome P450,1A1 ** 3.97 3.62 5.61 2.47 3.51 3.90 3.47 3.75 7
#
BG306468 TIPARP homolog ** 1.97 0.57 1.64 2.03 1.69 NS 1.02 1.40 6
#
AI959735 SULT6B1 homolog 2.96 NS 2.29 NS 1.59 1.67 1.98 1.42 5
#
BM183152 CDNA clone IMAGE:7177046 2.82 0.95 3.73 NS NS 2.41 1.01 1.02 5
#
AW232207 Transcribed locus 3.17 NS NS 1.76 NS 3.24 1.16 2.58 4
#
BI430015 Zgc:92102 2.36 1.26 1.13 NS NS 1.59 NS 1.14 4
#
AI601682 CYB5A homolog 1.64 NS 3.33 NS NS 3.10 1.42 1.76 4
#
AF063446 Aryl hydrocarbon receptor 2 ** 1.41 0.81 NS 1.06 NS NS 1.70 0.82 4
#
BI891596 NQO1 homolog ** 1.49 NS 1.49 NS NS 1.00 NS 1.02 3
AF285098 Glutathione S-transferase pi ** 1.00 NS 2.00 NS 1.09 1.15 NS NS 3
BM025955 * Transcribed locus 3.23 NS NS NS NS 1.40 NS 1.40 2
BG303549 Carbonic anhydrase II 2.06 NS NS NS NS 2.33 NS 20.64 2
AW232794 * Sortilin 1 1.31 0.44 NS NS NS 0.52 NS NS 2
AI477969 GRHL3 homolog 0.96 NS NS NS NS 0.80 1.59 NS 2
BI878941 * Zgc:77849 1.15 NS NS 1.00 NS NS NS NS 1
BG304178 * Transcribed locus 0.49 NS NS NS NS NS 0.65 NS 1
AI353694 GIF homologˆ 1.63 NS NS NS NS NS NS 21.23 1
AI793886 * Wu:fc55f04ˆ 0.34 NS NS NS NS NS NS NS 0
AI397347 KRT17 homolog 20.81 20.50 NS NS 20.65 20.82 NS 21.20 4
#
AW018635 * Transforming growth factor, beta-induced 20.71 20.48 20.81 21 . 5 3 N SN SN SN S3
BG304220 * Wu:fl33b06 21.18 NS 1.05 20.91 NS NS NS 20.68 3
AF295407 * Alcohol dehydrogenase 8a 21.57 NS NS 21.23 NS NS 21.29 21.12 3
AW421939 * Hm:zeh1207 21.07 NS NS 21.00 20.62 NS NS NS 2
AW233556 * Wu:fj37e01 20.33 NS NS NS NS NS NS 20.35 1
AF064835 * Eukaryotic translation elongation factor 2 * 20.41 NS NS 20 . 4 3 N SN SN SN S1
AI667240 Carboxypeptidase B1 21.03 NS NS NS 20.94 NS NS NS 1
Total Number of Positive Hits: 9 11 11 8 14 11 17 31
Percentage of Positive Hits: 29.03% 35.48% 35.48% 25.81% 45.16% 35.48% 54.84%
*Not in the Discriminatory Gene Sets.
**Known P(H)AHs-responsive genes.
***All values shown are significant (P-value,0.05, n=4) by heteroscedastic T-Test when compared to their respective control group.
ˆInconsistent with whole fish real-time PCR validated data.
NS: Not Significant (P-value.0.05).
#Confirmed as robust biomarker genes based on their significant deregulation in .50% tissues examined.
doi:10.1371/journal.pgen.1000121.t001
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(Table S5 and S6), such as reproductive, respiratory, dermatolog-
ical/connective tissue, digestive/metabolic, nervous/neurological
and visual/ophthalmic, corroborated with our multiple targeted-
tissue analysis which showed that many of the biomarkers were
deregulated in these tissues (Tables 1 and 2; Figure S2), suggesting
that they are good ‘biomarkers of effect’.
Thus, a whole-adult-organism representation fits well for
human health-risk inferences as the biological information are
obtained, not from single tissue but multiple tissues interacting in
a complex biological system where diseases/disorders usually
develop or off-target effects occur. Incidentally, while zebrafish has
always been used to model after human diseases [8], here we
demonstrate the potential of zebrafish for predicting disease
susceptibility or health risk associated with the exposure to a
compound, and this in turn can further help to develop chemical-
induced zebrafish models of human diseases.
Novel Biological Insights Inferences
A closer examination of the top connected networks generated
by IPA using P(H)AH and EC datasets revealed interesting
biological insights (Figure 6). In the P(H)AH network (Figure 6A;
Table 2. Real-Time PCR of validated genes for identification of biomarkers in selected tissue samples from fish treated with DES
(5ug/L) for 72 hours.
Tissue Types (Log2 Fold Difference Treated vs. Normal) ***
Number of
Positive
Tissue
GenBank Acc Description
Whole
Fish Brain Gill Liver Gut Skin Testis Eye
AF406784 vitellogenin 1 ** 12.30 NS 3.69 12.94 12.14 9.95 7.71 3.73 6
#
AF254638 Vitellogenin 3, phosvitinless ** 12.87 NS NS 10.62 9.88 7.33 5.85 2.79 5
#
AF349412 Estrogen receptor 1 ** 4.60 21.00 1.08 3.02 3.49 1.81 NS NS 5
#
BI889078 High density lipoprotein-binding protein 1.31 NS NS 4.51 0.80 0.86 0.93 20.63 5
#
BI882727 Signal sequence receptor, alpha 1.19 NS 20.79 4.13 0.84 0.83 NS 20.35 5
#
AW175541 Wu:fi36e01 2.29 NS 21.50 5.84 NS 1.49 NS 21.04 4
#
BI896378 Zgc:66313 1.65 NS 21.27 2.90 1.41 3.07 NS NS 4
#
BM182319 Solute carrier family 31, member 1 1.40 NS NS 3.99 NS 1.33 1.01 20.37 4
#
BF717944 Transcribed locus 4.74 NS NS 9.35 4.68 3.89 NS NS 3
BG891864 Carboxypeptidase N, polypeptide 1 2.88 NS NS 4.86 1.93 2.42 NS NS 3
BM082666 Zgc:92744 1.97 NS NS 3.92 0.67 1.40 NS NS 3
BF717555 nuclear protein 1 3.52 NS NS 4.69 NS 1.13 NS NS 2
BI427744 FK506 binding protein 11 ** 3.31 NS NS 8.33 NS 2.61 NS NS 2
AI522628 Wu:fb60e09 1.74 NS NS 3.39 NS 1.82 NS NS 2
BI878941 * Zgc:77849 0.73 NS NS 1.64 NS 0.77 NS NS 2
BI885968 Signal sequence receptor, delta 1.37 NS NS 3.19 NS NS NS NS 1
BI981380 * Wu:fj36g07ˆ 0.38 22 . 7 6 N SN SN S N SN S21.87 2
BI839255 Wu:fb78c04ˆ 0.59 21 . 9 0 N SN SN S N SN SN S1
AW115757 Hemopexin 23.23 NS 22.06 27.68 28.12 23.67 25.76 21.45 6
#
BF717503 Serine/cysteine proteinase inhibitor C1 20.89 21.13 21.15 25.39 21.93 NS 23.35 NS 5
#
AW342687 Cytochrome P450,1A 20.95 NS 21.00 21.95 21.32 22.21 NS 20.71 5
#
AW019124 * Alanine-glyoxylate aminotransferase 21.47 NS 20.80 20.85 21.82 NS NS 21.01 4
#
BG985468 * Fructose-1,6-bisphosphatase 1 22.09 NS 22.01 23.99 21.30 NS 25.09 NS 4
#
AI722510 * MGC:103610 IMAGE:7250917 22.11 NS NS 21.76 23.31 NS 21.65 22.67 4
#
AW019201 Complement Component 9 22.35 NS NS 23.21 24.78 NS 22.84 21.92 4
#
AF057713 * Cytochrome P450,1A1 20.65 NS NS 21.31 21.06 NS 21.66 NS 3
BF156623 Uncoupling protein 4 21.83 NS NS 25.17 21.75 NS NS 22.32 3
AW421213 * Phenylalanine hydroxylase 20.68 NS NS 20.91 22.62 NS NS NS 2
Total Number of Positive Hits: 4 10 26 19 17 10 13 29
Percentage of Positive Hits: 13.79% 34.48% 89.66% 65.52% 58.62% 34.48% 44.83%
*Not in the Discriminatory Gene Sets.
**Known Estrogen-responsive genes.
***All values shown are significant (P-value,0.05, n=4) by heteroscedastic T-Test when compared to their respective control group.
ˆInconsistent with whole fish real-time PCR validated data.
NS: Not Significant (P-value.0.05).
#Confirmed as robust biomarker genes based on their significant deregulation in .50% tissues examined.
doi:10.1371/journal.pgen.1000121.t002
Zebrafish Chemogenomics
PLoS Genetics | www.plosgenetics.org 8 July 2008 | Volume 4 | Issue 7 | e1000121P-value=1.00610
239) the well-established xenobiotic-responsive
molecules (AHR, CYP1A1, CYP1B1, CYP2C19, HSP90AB1,
NFE2L2, NQO1, TIPARP) were linked with key signaling
molecules such as NR3C1/GR, STAT1 and IGF1 providing
new insights into alternative mechanisms of how P(H)AHs could
exert adverse effects resulting in various pathological conditions.
Notably in Table S5, 6 categories of P(H)AH-related diseases/
disorders were found to be associated with AHR, NR3C1/GR,
STAT1 and IGF1, while all 24 categories of the related diseases/
disorders were associated with at least one of the four molecules.
Interestingly, it was only recently that stronger evidence of cross-
talk between AHR and NR3C1/GR are emerging [36,37]. Our
Figure 4. Human homolog mapping, biological function and health-risk inferences for P(H)AH consolidated gene set. (A) 119 genes
(among 156) were mapped to human homologs (with human Unigene identity) and used for Ingenuity knowledge-based data mining. Only 68 (57%)
of the human homologs from the P(H)AH gene set were found to be associated with certain biological data in Ingenuity and used for subsequent
analysis which generated three categories of data: (B) Molecular and Cellular Functions, (C) Physiological System Development and Function, and (D)
Diseases and Disorders. Histograms are read with reference to ‘Percentage of Human Homologs Used in Analysis’ axis while solid and dashed lines are
read with reference to ‘-Log P-value’ axis. ‘Percentage of Human Homologs Used in Analysis’ refers to the percentage of the total 68 human
homologs used in the analysis. Solid line represents the inverse logarithm (base 10) of the P-value for each group of biological association [greater –
Log (P-value) correlates with greater statistical significance], while the dashed line represents the significant threshold where the P-value=0.05. Only
the top 10 features with the highest percentage of human homologs involved and which are statistically significant are shown (see Table S6 for more
information).
Zebrafish Chemogenomics
PLoS Genetics | www.plosgenetics.org 9 July 2008 | Volume 4 | Issue 7 | e1000121analysis suggests that HSP90 [38] may be one of the mediators, as
also observed in the relatively more studied AHR-ER cross-talk
[39]. As both NR3C1/GR and STAT1 are known regulators of
inflammatory and immune response [40], respectively, the AHR-
NR3C1/GR cross-talk may be another pathway that could
contribute to the known immuno-toxicity effects of P(H)AHs
[41]. The opposing direction of expression for CYP1A1 and
CYP2C19, as displayed in both P(H)AHs and ECs networks
(Figure 6), are evidence of inhibitory cross-talk between AHR and
ER. While CYP1A1 is a known targeted molecule of this
inhibitory AHR-ER cross-talk [32], this is the first time a member
of the CYP2 family that includes important drug metabolizing
enzymes is implicated and its regulation appeared opposite to
CYP1A1. Apart from the xenobiotic-responsive molecules, the
ECs network (Figure 6B; P-value=1.00610
257) linked clusters of
molecules associated with proteasome-mediated degradation
Figure 5. Human homolog mapping, biological function and health-risk inferences for EC consolidated gene set. (A) 123 genes
(among 155) were mapped to human homologs (with human Unigene identity) and used for Ingenuity knowledge-based data mining. Only 70 (57%)
of the human homologs from the EC gene set were found to be associated with biological data in Ingenuity and used for subsequent analysis which
generated three categories of data: (B) Molecular and Cellular Functions, (C) Physiological System Development and Function, and (D) Diseases and
Disorders (see Figure 4 legend for remaining description).
doi:10.1371/journal.pgen.1000121.g005
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reticulum stress response (FKBP11, HM13, RRBP1, PDIA4,
SRPRB, SSR1, SSR2, XBP1), and cell cycle/death (CISH,
FKBP4, P8, PA2G4, PTCH1), providing insights into cellular
homeostasis and pathology associated with ECs and ER [19,42].
The linking of the 5 known estrogen-responsive transcription
factors PSMC5/SUG1, XBP1, P8, PA2G4 and ESR1 suggests
that, under the influence of ECs, these transcription factors play
important roles in mediating endoplasmic-reticulum stress re-
sponse, proteasome-mediated degradation and cell cycle/death,
thus offering new insights into the regulation of ‘unfolded protein
response’ which has been intensely studied due to its association
with diseases, drug resistance and its potential as therapeutic
targets [43–45]. While further investigation is warranted, the
analysis demonstrate the discovery potential of zebrafish whole-
adult-chemogenomics and serve the purpose of alerting the
researcher of the potential molecular interactions and effects
induced by the compounds at the early drug discovery stage.
In summary, we have demonstrated that zebrafish whole-adult-
organism chemogenomics is practical and effective for large-scale
predictive and discovery chemical biology. Specifically, we have
generated robust prediction models, identified and validated
Figure 6. Gene network analysis for biological insights inference. Top networks for (A) P(H)AHs and (B) ECs were generated by Ingenuity
Pathway Analysis (IPA) software. Up- and down-regulated genes are indicated in red and green symbols, respectively. Non-colored genes are not in
the discriminatory gene sets but are associated with the deregulated genes and are introduced by the software to link up the network.
doi:10.1371/journal.pgen.1000121.g006
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signaling pathways and biological functions as well as inferred
human health risks and biological insights for both P(H)AHs and
ECs. As strong and well-represented expression signals are likely to
be captured, this approach is valuable for acquiring a molecular
snapshot of the chemical-induced biological state of an adult
vertebrate, which includes biomarkers of effects, deregulated
signaling pathways, as well as possible affected biological functions,
perturbed physiological systems and increased health risks.
Moreover, this approach allows for rapid sampling in large-scale
experiments, abundant sample materials for assays (does not
require pooling or amplification of samples) and easy scaling-up of
experiments, hence affords greater statistical power for data
analysis. These are essentials for successful high-throughput
genomics applications and for building up large database for
predictive chemical biology [2]. The zebrafish is more cost-
effective than the rodent model for in vivo toxicology [12,13] and
there had been proposals and successful attempts of using chemical
screens and toxicity testing in whole-adult zebrafish as there are
biological processes and diseases that are mainly associated with
adults [9,46]. Therefore, with zebrafish, cost-effective in vivo adult
vertebrate chemogenomics can be performed earlier in the drug
discovery process and for industrial/environmental toxicology,
where high resolution tissue-specific data is yet required but robust
and informative in vivo toxicological data is deemed valuable. This
will enable researchers to better understand the potential liabilities
of new compounds before advancing them to clinical test and may
help shift attrition upstream [2,47,48] or before allowing contact
with the public or releasing them to the environment. This present
study has provided a new strategy for genome-wide investigation
of chemical-induced biological responses/effects in a whole-adult
vertebrate model; where previously such whole-adult-organism
chemogenomics approach were thought only feasible in inverte-
brate models. The realization of its potential can benefit the drug
discovery process and toxicology, in particular chemical toxicity
testing for environmental health-risk inference.
Materials and Methods
Chemical Exposure and Fish Samples
Three independent experiments (‘A’, ‘B’ and ‘C’) were
performed in this study where different batches of adult male
zebrafish were exposed to various chemical compounds at
different concentrations (Table S1). The selected chemicals
represent compounds with toxicological interests and/or environ-
mental-health importance, and the concentrations used were
based on available published data or our preliminary acute toxicity
exposure experiments conducted for the compounds. Experimen-
tal procedures were performed within the guidelines of National
University of Singapore’s Institutional Animal Care and Use
Committee (NUS-IACUC). The fish were immersed in the
chemical solutions for 96 hours [experiment ‘A’] or 72 hours
[experiment ‘B’ and ‘C’] at a density of 1 fish/200 ml at 2762uC
in a static condition. Control fish were kept in vehicle solution or
water under similar condition. Chemical solutions and water were
changed daily. At the end of experiment, individual whole fish
were snap-frozen and pounded to powder in liquid nitrogen for
subsequent total RNA extraction using Trizol reagent (Invitrogen,
USA) protocol. For experiment ‘C’, specific tissues were snap-
frozen in liquid nitrogen for total RNA extraction using RNeasy
Mini Kit (QIAGEN, Germany) followed by DNAseI treatment
and heat inactivation. Reference RNA was obtained by pooling
total RNA extracted from male and female zebrafish. The
integrity of RNA samples was verified by gel electrophoresis,
and the concentrations were determined by UV spectrophotom-
eter.
Zebrafish Oligonucleotide Microarray and Hybridization
The oligonucleotide probes for this array were designed by
Compugen (USA) and synthesized by Sigma Genesis (USA). The
arrays contained 16,416 oligonucleotide probes. The probes were
resuspended in 36SSC at 20 mM concentration and spotted onto
in-house poly-L-lysine-coated microscope slides using a custom-
built DNA microarrayer in the Genome Institute of Singapore
(GIS). The arrays were spotted and quality controlled essentially as
described by Eisen and Brown [49].
For fluorescence labeling of cDNAs, 20 mg of total RNA from
the reference and sample RNAs were reverse transcribed in the
presence of dNTPs mixed with Aminoallyl-dUTP (Sigma, USA)
followed by coupling with mono-functional NHS-ester Cy3 and
Cy5 dyes (Amersham, USA), respectively. A common reference
design is used where equal amount of RNA samples from control
and chemical-treated group were labeled with Cy5 and the same
amount of common pooled reference RNA is labeled with Cy3.
For each array, the Cy5-labeled samples from either the control or
chemical-treated group was co-hybridized with the Cy3-labeled
common reference. Thus, the respective paired Cy5- and Cy3-
labeled cDNAs were pooled, concentrated, and resuspended in
DIG EasyHyb (Roche Applied Science) buffer for hybridization at
42uC for 16 h in a hybridization chamber (Gene Machines). After
hybridization, the slides were washed in a series of washing
solutions (26SSC with 0.1% SDS, 16SSC with 0.1% SDS, 0.26
SSC and 0.056 SSC; 30 sec each), dried using low-speed
centrifugation, and scanned for fluorescence detection.
Data Acquisition
The arrays were scanned using the GenePix 4000B microarray
scanner (Axon Instruments, USA) and the generated images with
their fluorescence signal intensities were analyzed using GenePix
Pro 4.0 image analysis software (Axon Instruments, USA). All the
arrays gave a mean signal to background ratio more than 5 and
had .90% of the gene features that gave a measurable signal.
Only gene features that were not flagged were extracted and
subjected to Lowess normalization for further analyses. The
microarray raw data have been formatted to be compliant with
MIAME standard.
Statistical Procedures for Microarray Data
Statistical comparison of the relative mean expression level for
each gene between test groups [combined representative groups of
P(H)AHs or ECs] and their respective control groups from Dataset
I or III were performed using Student’s T-test and Significance
Analysis of Microarray [50] (SAM) yielding respective P- and Q-
values for each gene. The resulting P-values were further adjusted
for Benjamini and Hochberg False Discovery Rate (FDR). The
discriminatory gene sets were selected based on statistical
threshold indicated by Q-value, FDR-value and P-value coupled
with 1.5 fold-difference between treated versus control samples
(Figure S1 and Table S2). The discriminatory gene sets together
with their expression data in Dataset I or III were used to train two
supervised learning classifiers, kNN and SVM, which generated
prediction models for P(H)AHs class and ECs class. The procedure
includes a training phase and a testing phase. In the training
phase, the discriminatory gene sets together with their expression
data from Dataset I or III were used as inputs to produce a set of
rules or reference weights as standards/models for the testing
phase. A ‘leave-one-out’ cross-validation is usually incorporated to
validate the goodness of the model to avoid ‘over-fitting’ it (i.e.
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generalize to work well on other new and unknown datasets). The
testing phase uses the standards created during ‘training’ to assign
a discriminator score to each unseen (not used in the training) or
unseen sample. Based on this score each sample is placed ‘into’ or
‘out of’ the class and their performances in terms of prediction
specificity and sensitivity were determined (Figure 1 and 2; Table
S3). Fisher’s Exact Test was further used to determine that the
performances of the prediction models were non-random.
Quantitative Real-Time PCR
Equal amounts of total RNA samples from reference, control
and test groups were reverse transcribed to cDNA. The cDNA
samples were used for quantitative real-time PCR analysis,
performed using the Lightcycler system (Roche Applied Science)
with Lightcycler-FastStart DNA Master SYBR Green 1 (Roche
Applied Science) according to the manufacturer’s instructions.
Statistical comparison of the relative mean expression level for
each gene between test and control groups was performed using
Student’s T-test and P-value,0.05 is considered significant.
Human Health-Risk and Biological Insights Inference via
Knowledge-Based Data Mining
To evaluate the potential for human health-risk inference, the
zebrafish genes were mapped to their corresponding human
homologs using the GIS Zebrafish Microarray Annotation
Database (http://giscompute.gis.a-star.edu.sg/,govind/unige-
ne_db/) http://giscompute.gis.a-star.edu.sg/,govind/zebrafish/
version2/as previously described [14]. The human homologs of
the zebrafish genes from the consolidated gene sets P(H)AHs and
ECs were used to mine the human database via Ingenuity
Pathways Knowledge Base software (www.ingenuity.com). The
‘Biological and Disease Function Analysis’ was performed to
identify biological functions and systems as well as diseases/
disorders that were significantly associated with the gene sets.
Fisher’s Exact test was used to calculate P-values in determining
the probability that each biological function, system and disease
assigned to that data set is due to chance alone. P-value,0.05 is
considered significant by the algorithm. Networks are generated
from the available human homologs mapped from the discrim-
inatory gene sets, by maximizing the specific connectivity of the
human homologs, which is their interconnectedness with each
other relative to all molecules they are connected to in Ingenuity’s
Knowledge Database. Networks are limited to 35 molecules each
to keep them to a functional size and a network score is generated
based on the hypergeometric distribution and is calculated
with the right-tailed Fisher’s Exact Test. In this study, only the
top network for the consolidated gene sets P(H)AHs (P-
value=1.00610
239) and ECs (P-value=1.00610
257) were used
for further analysis.
Supporting Information
Figure S1 An overview of the workflow for large-scale predictive
and discovery chemical biology using whole-adult zebrafish
chemogenomics.
Found at: doi:10.1371/journal.pgen.1000121.s001 (1.12 MB PDF)
Figure S2 Summary of real-time PCR validated genes for
identification of biomarkers in 7 selected targeted tissues (brain,
gill, liver, gut, skin, testis and eyes).
Found at: doi:10.1371/journal.pgen.1000121.s002 (0.38 MB PDF)
Table S1 Array samples and concentration of chemical
treatments used in the study.
Found at: doi:10.1371/journal.pgen.1000121.s003 (0.05 MB PDF)
Table S2 Selection criteria and number of genes selected for
discriminatory gene sets used for training of prediction models.
Found at: doi:10.1371/journal.pgen.1000121.s004 (0.01 MB PDF)
Table S3 Summary of the performance of prediction models
trained using Dataset I (Figure 1) and Dataset III (Figure 2).
Found at: doi:10.1371/journal.pgen.1000121.s005 (0.05 MB PDF)
Table S4 Selected BAP- or DES- responsive genes validated to
be significant (P,0.05) in whole fish using real-time PCR.
Found at: doi:10.1371/journal.pgen.1000121.s006 (0.03 MB PDF)
Table S5 Biological associations of the P(H)AH-deregulated
human homologs (68) generated by Ingenuity Pathway Analysis
(IPA) software.
Found at: doi:10.1371/journal.pgen.1000121.s007 (0.05 MB PDF)
Table S6 Biological associations of the EC-deregulated human
homologs (70) generated by Ingenuity Pathway Analysis (IPA)
software.
Found at: doi:10.1371/journal.pgen.1000121.s008 (0.05 MB PDF)
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